New research on long COVID prevalence and risk factors

FHS
June 18, 2024
5:28 am

Early in the pandemic, many people who had SARS-Cov-2 infection or COVID-19 began to report that they couldn’t shake off their symptoms even after a month or more-;unusually long for a viral infection of the upper respiratory tract-;or developed new, persistent symptoms soon after the infection cleared.

IDWeek 2024: strategic approaches and challenges in mpox vaccination – Pharmaceutical Technology

At IDWeek 2024 in Los Angeles, California, recent updates on mpox (formerly known as monkeypox) were discussed. Significant advancements and remaining hurdles in vaccination strategies

November 12, 2024

Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product | Psychedelic Invest

Vancouver, Canada, May 10, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of

May 10, 2024

Novovax’s Omicron-targeting Covid-19 vaccine obtains WHO emergency listing – Pharmaceutical Technology

Share this article Novavax’s vaccine can be stored at 2°C-8°C and has a shelf life of 12 months. Credit: Morsa Images via Getty Images. Novovax

November 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.